Cardiovascular Mortality Associated With Abnormal Calcium Metabolism

This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00018395
First received: July 3, 2001
Last updated: January 20, 2009
Last verified: December 2004
  Purpose

The purpose of this cohort study is to estimate the risk of cardiovascular mortality associated with abnormal calcium metabolism


Condition
Cardiovascular Disease
Kidney Disease

Study Type: Observational
Official Title: Cardiovascular Mortality Associated With Abnormal Calcium Metabolism

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Study Start Date: August 1997
Estimated Study Completion Date: June 2002
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

All ESRD patients who indicated dialysis in 1990-1993

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00018395

Locations
United States, Washington
VA Puget Sound Health Care System
Seattle, Washington, United States, 98108
Sponsors and Collaborators
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00018395     History of Changes
Other Study ID Numbers: CADE-AI
Study First Received: July 3, 2001
Last Updated: January 20, 2009
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Calcium Metabolism

Additional relevant MeSH terms:
Cardiovascular Diseases
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on April 22, 2014